Sarah Howell
Vorstandsvorsitzender bei ARECOR THERAPEUTICS PLC
Vermögen: 1 Mio $ am 30.04.2024
Aktive Positionen von Sarah Howell
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ARECOR THERAPEUTICS PLC | Direktor/Vorstandsmitglied | - | - |
Vorstandsvorsitzender | - | - | |
Investor Relations Kontakt | - | - | |
Geschäftsführer | - | - | |
Arecor Ltd.
Arecor Ltd. BiotechnologyHealth Technology Arecor Ltd. provides stabilization technology solutions. The firm's products include ultra-rapid acting prandial insulin, stable aqueous glucagon, ultra concentrated insulin and additional programs. The company was founded by Paul James Davis in 2007 and is headquartered in Cambridge, the United Kingdom. | Direktor/Vorstandsmitglied | 10.11.2011 | - |
Vorstandsvorsitzender | 01.01.2015 | - | |
Geschäftsführer | 10.11.2011 | 01.01.2015 |
Karriereverlauf von Sarah Howell
Ehemalige bekannte Positionen von Sarah Howell
Ausbildung von Sarah Howell
University of St. Andrews | Doctorate Degree |
University of Birmingham | Undergraduate Degree |
Statistik
International
Vereinigtes Königreich | 7 |
Belgien | 2 |
Operativ
Corporate Officer/Principal | 3 |
Director/Board Member | 2 |
Chief Executive Officer | 2 |
Sektoral
Health Technology | 6 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
UCB | Health Technology |
GSK PLC | Health Technology |
ARECOR THERAPEUTICS PLC | Health Technology |
Private Unternehmen | 2 |
---|---|
Arecor Ltd.
Arecor Ltd. BiotechnologyHealth Technology Arecor Ltd. provides stabilization technology solutions. The firm's products include ultra-rapid acting prandial insulin, stable aqueous glucagon, ultra concentrated insulin and additional programs. The company was founded by Paul James Davis in 2007 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
BTG Ltd.
BTG Ltd. Pharmaceuticals: MajorHealth Technology BTG Ltd. is a global healthcare company, which focuses on interventional medicine that can help physicians to treat patients through minimally invasive procedures. It operates through the following segments: Product, Licensing, and Other. The firm's products include CroFab, DigiFab, Voraxage. The company was founded on December 12, 1991 and is headquartered in Farnham, the United Kingdom. | Health Technology |
- Börse
- Insiders
- Sarah Howell
- Erfahrung